Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer

BACKGROUND: Anti-depressants have been reported to own anti-tumor potential types of cancers; however, the role of imipramine in non-small cell lung cancer (NSCLC) has not been elucidated. Epidermal growth factor receptor (EGFR) was known to be one of the key regulators that control NSCLC progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yueh, Po-Fu, Lee, Yuan-Hao, Chiang, I-Tsang, Chen, Wei-Ting, Lan, Keng-Li, Chen, Cheng-Hsien, Hsu, Fei-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576332/
https://www.ncbi.nlm.nih.gov/pubmed/34765548
http://dx.doi.org/10.3389/fonc.2021.735183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576332/
https://www.ncbi.nlm.nih.gov/pubmed/34765548
http://dx.doi.org/10.3389/fonc.2021.735183

Ejemplares similares